跳至主要内容
临床试验/CTRI/2024/04/066513
CTRI/2024/04/066513尚未招募不适用

A study to assess the comparative efficacy of Ferrum Phosphoricum 3X and Individualized homoeopathic medicine in the management of Iron deficiency anemia

Dr Arshi1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年5月8日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Blood Hb% and serum ferritin level

研究概览

简要总结

Iron deficiency anemia stands out as the predominant cause of anemia globally. Individuals affected by this condition frequently experience non-specific symptoms like fatigue and dyspnea on exertion and it can significantly impact daily activities of individual. Approximately 30% of the global population is affected by anemia, and half of these cases are attributed to iron deficiency. Iron deficiency anemia occurs when iron losses or physiological requirements exceed absorption. This study will compare the effectiveness of homoeopathic individualized medicine and  Ferrum Phosphoricum-3X in the management of Iron deficiency anemia. 60 patients will be enrolled and will be categorized into two groups of 30 patients each. One group will receive Ferrum Phosphoricum-3X while the other will be given homoeopathic individualized medicine based on the totality of symptoms. Each patient will be evaluated regularly. The result will be assessed through the level of hemoglobin and serum ferritin.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
15.00 Year(s) 至 49.00 Year(s)(—)
性别
All

入选标准

  • Patients with clinical symptoms of iron deficiency anemia 2)Patient having hemoglobin level ≤ 11.9g/dl and ≥ 8g/dl 3) Patient having Serum Ferritin less than 30 microgram/l 4)Patients providing written informed consent.

排除标准

  • Patients with hemoglobin levels ≤ 7.9 g/dl (severe anemia) 2)Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled systemic illness or life- threatening infections affecting quality of life or any vital organ failure.
  • Pregnancy and lactation 4)Substance abuse and/or dependence 5)Self-reported immune-compromised state 6)Patients who are already enrolled in some other study.
  • Patient unwilling for inclusion in the study and those who are not able to come for follow-up.

结局指标

主要结局

Blood Hb% and serum ferritin level

时间窗: At baseline and after every 3 months

次要结局

  • Fatigue severity scale (FSS) scores(At baseline and after 6 months)

研究者

发起方
Dr Arshi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Arshi

State National Homoeopathic Medical College And Hospital

研究点 (1)

Loading locations...

相似试验